Druie Cavender
Papers
1
Total Citations
8
H-Index
1
About
Dr. Druie Cavender is a distinguished pharmacologist whose research has centered on G protein-coupled receptors (GPCRs) and high-throughput screening (HTS) assay development, with a particular focus on the adenosine A2a receptor. His most cited work, a 2004 study on developing a sensitive and HTS-compatible reporter gene assay for functional analysis of human adenosine A2a receptors in CHO-K1 cells, has garnered 8 citations and represents a significant methodological contribution to the field. This work enabled efficient, scalable investigation of this important pharmacological target, which couples to stimulatory G proteins and activates adenylate cyclase. Dr. Cavender's major contributions lie in bridging molecular pharmacology and drug discovery, providing tools that accelerate the identification of therapeutic compounds targeting GPCRs. His assay development expertise has facilitated functional analysis of receptor signaling pathways, impacting both basic research and pharmaceutical development. Through his innovative approaches to cell-based assays, Dr. Cavender has helped advance our understanding of receptor pharmacology and enabled more efficient screening of potential drug candidates, making him a notable figure in the evolution of modern drug discovery methodologies.
Research Focus
Key Achievements
Top Papers
- 1